Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations

Medicine, Genetics, Oncology +14

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer

Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations

Medicine, Molecular Biology, Oncology +15

Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer

Jianzhong Shou, Suleiman Massarweh, C. K. Osborne et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Matthew J. Ellis, Andrew Coop, Baljit Singh et al. · Journal of Clinical Oncology · 2001 · 1.1K citations · Full text

Medicine, Endocrinology, Oncology +17

Neu-Protein Overexpression in Breast Cancer

Marc J. van de Vijver, Johannes L. Peterse, Wolter J. Mooi et al. · New England Journal of Medicine · 1988 · 867 citations

Medicine, Oncology, Pathology +15